WYETH

Wyeth Limited has informed the Exchange that "Further to our communication dated October 31, 2014 in connection with the approval by the Hon'ble High Court of Judicature at Bombay to the Scheme of Amalgamation between the Company and Pfizer Limited, and their respective shareholders and creditors under the provisions of Sections 391 to 394 of the Companies Act, 1956 ("Scheme"), we wish to inform you that the Scheme has become effective on December 1, 2014 ("Effective Date") after filing of e-Form INC - 28 with the Registrar of Companies / Ministry of Corporate Affairs".

Wyeth Limited has informed the Exchange that the Hon'ble High Court of Judicature at Bombay on October 31, 2014, considered and approved the amalgamation of the Company with Pfizer Limited, in terms of the Scheme of Amalgamation between the Company, Wyeth Limited and their respective shareholders and creditors under the provisions of Sections 391 to 394 of the Companies Act, 1956.

Wyeth Limited has informed the Exchange that "Wyeth, USA has entered into a definitive Merger Agreement with Pfizer, USA under which Pfizer, USA will acquire Wyeth, USA in a cash-and-stock transaction. The combined company will create one of the most diversified companies in the global health care industry".